NCT01630148View on ClinicalTrials.gov

Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

NACompletedINTERVENTIONAL

Enrollment

774

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Deep Vein Thrombosis (DVT)Pulmonary Embolism

Interventions

DRUG

Bemiparin

Bemiparin Sodium 3,500IU anti Xa/0.3 ml solution for injection in pre-filled syringe will be provided for each patient in Bemiparin group (Moderate, High and Highest risk groups for thromboembolism) 6 hours after surgery and then daily for up to 7 days.

Trial Locations (1)

44001

Shahla Kareem Alalaf, Erbil

All Listed Sponsors

lead

Hawler Medical University

OTHER

NCT01630148 - Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries | Biotech Hunter | Biotech Hunter